 |
PDBsum entry 3cvr
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.3.2.27
- RING-type E3 ubiquitin transferase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N6- ubiquitinyl-[acceptor protein]-L-lysine
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Nat Struct Biol
15:1302-1308
(2008)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure of a Shigella effector reveals a new class of ubiquitin ligases.
|
|
Y.Zhu,
H.Li,
L.Hu,
J.Wang,
Y.Zhou,
Z.Pang,
L.Liu,
F.Shao.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Bacterial pathogens have evolved effector proteins with ubiquitin E3 ligase
activities through structural mimicking. Here we report the crystal structure of
the Shigella flexneri type III effector IpaH3, a member of the leucine-rich
repeat (LRR)-containing bacterial E3 family. The LRR domain is structurally
similar to Yersinia pestis YopM and potentially binds to substrates. The
structure of the C-terminal E3 domain differs from the typical RING- and
HECT-type E3s. IpaH3 synthesizes a Lys48-linked ubiquitin chain, and the
reaction requires noncovalent binding between ubiquitin and a specific E2,
UbcH5. Free ubiquitin serves as an acceptor for IpaH3-catalyzed ubiquitin
transfer. Cys363 within a conserved CXD motif acts as a nucleophile to catalyze
ubiquitin transfer through a transthiolation reaction. The D365N mutant is
devoid of E3 activities but turns into a potent ubiquitin-E2 thioesterase. Our
analysis establishes a structurally and mechanistically distinct class of
ubiquitin ligases found exclusively in pathogenic or symbiotic bacteria.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
(a) Stereo view of the overall structure of full-length
IpaH3. The structure consists of two domains: the N-terminal
leucine-rich repeat (LRR) domain (gold) and the C-terminal
helical domain (green) with the E3 ligase activity. Secondary
structures are marked with numbered labels, and broken lines
indicate disordered loop regions. (b) Secondary-structure
organization and amino acid compositions of the nine LRR motifs
in IpaH3. Secondary-structural elements are depicted along and
above the sequence. The consensus sequences of LRR1–LRR7 are
highlighted in green and the YopM sequence is listed underneath
for comparison. (c) Backbone superimposition of the structures
of YopM (blue; PDB 1JL5) and the LRR domain of IpaH3 (gold).
|
 |
Figure 3.
(a) Structure of the C-terminal E3 ligase domain of IpaH3.
Secondary structures are marked with numbered labels, and broken
lines indicate disordered loop regions. Cys363 and Asp365, which
are important for catalyzing ubiquitin transfer, are highlighted
in yellow and shown in sticks. (b) Representative structures of
RING-finger and U-box E3 ligases. The RING-finger and U-box
domains were selected from RING-type E3 ligase Cbl (PDB 1FBV)
and U-box E3 ligase Ufd2p (PDB 2QIZ), respectively. The zinc
ions in Cbl are colored orange. (c) Structure of the HECT domain
of E6AP (PDB 1D5F). The N and C lobes are colored red and
purple, respectively. The catalytic cysteine (Cys820) and the
hinge loop connecting the two lobes are indicated.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Macmillan Publishers Ltd:
Nat Struct Biol
(2008,
15,
1302-1308)
copyright 2008.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
D.Y.Lin,
J.Diao,
D.Zhou,
and
J.Chen
(2011).
Biochemical and structural studies of a HECT-like ubiquitin ligase from Escherichia coli O157:H7.
|
| |
J Biol Chem,
286,
441-449.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
H.Ashida,
M.Ogawa,
M.Kim,
S.Suzuki,
T.Sanada,
C.Punginelli,
H.Mimuro,
and
C.Sasakawa
(2011).
Shigella deploy multiple countermeasures against host innate immune responses.
|
| |
Curr Opin Microbiol,
14,
16-23.
|
 |
|
|
|
|
 |
I.N.Okeke,
L.R.Macfarlane-Smith,
J.N.Fletcher,
and
A.M.Snelling
(2011).
IS3 profiling identifies the enterohaemorrhagic Escherichia coli O-island 62 in a distinct enteroaggregative E. coli lineage.
|
| |
Gut Pathog,
3,
4.
|
 |
|
|
|
|
 |
L.Bedford,
J.Lowe,
L.R.Dick,
R.J.Mayer,
and
J.E.Brownell
(2011).
Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets.
|
| |
Nat Rev Drug Discov,
10,
29-46.
|
 |
|
|
|
|
 |
O.Steele-Mortimer
(2011).
Exploitation of the ubiquitin system by invading bacteria.
|
| |
Traffic,
12,
162-169.
|
 |
|
|
|
|
 |
B.Wu,
T.Skarina,
A.Yee,
M.C.Jobin,
R.Dileo,
A.Semesi,
C.Fares,
A.Lemak,
B.K.Coombes,
C.H.Arrowsmith,
A.U.Singer,
and
A.Savchenko
(2010).
NleG Type 3 effectors from enterohaemorrhagic Escherichia coli are U-Box E3 ubiquitin ligases.
|
| |
PLoS Pathog,
6,
e1000960.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.A.Collins,
and
E.J.Brown
(2010).
Cytosol as battleground: ubiquitin as a weapon for both host and pathogen.
|
| |
Trends Cell Biol,
20,
205-213.
|
 |
|
|
|
|
 |
H.Ashida,
M.Kim,
M.Schmidt-Supprian,
A.Ma,
M.Ogawa,
and
C.Sasakawa
(2010).
A bacterial E3 ubiquitin ligase IpaH9.8 targets NEMO/IKKgamma to dampen the host NF-kappaB-mediated inflammatory response.
|
| |
Nat Cell Biol,
12,
66.
|
 |
|
|
|
|
 |
I.Levin,
C.Eakin,
M.P.Blanc,
R.E.Klevit,
S.I.Miller,
and
P.S.Brzovic
(2010).
Identification of an unconventional E3 binding surface on the UbcH5 ~ Ub conjugate recognized by a pathogenic bacterial E3 ligase.
|
| |
Proc Natl Acad Sci U S A,
107,
2848-2853.
|
 |
|
|
|
|
 |
J.Bernal-Bayard,
E.Cardenal-Muñoz,
and
F.Ramos-Morales
(2010).
The Salmonella type III secretion effector, salmonella leucine-rich repeat protein (SlrP), targets the human chaperone ERdj3.
|
| |
J Biol Chem,
285,
16360-16368.
|
 |
|
|
|
|
 |
J.Cui,
Q.Yao,
S.Li,
X.Ding,
Q.Lu,
H.Mao,
L.Liu,
N.Zheng,
S.Chen,
and
F.Shao
(2010).
Glutamine deamidation and dysfunction of ubiquitin/NEDD8 induced by a bacterial effector family.
|
| |
Science,
329,
1215-1218.
|
 |
|
|
|
|
 |
J.Peng,
J.Yang,
and
Q.Jin
(2010).
Research progress in Shigella in the postgenomic era.
|
| |
Sci China Life Sci,
53,
1284-1290.
|
 |
|
|
|
|
 |
M.Hentschke,
L.Berneking,
C.Belmar Campos,
F.Buck,
K.Ruckdeschel,
and
M.Aepfelbacher
(2010).
Yersinia virulence factor YopM induces sustained RSK activation by interfering with dephosphorylation.
|
| |
PLoS One,
5,
0.
|
 |
|
|
|
|
 |
M.W.McCoy,
M.L.Marré,
C.F.Lesser,
and
J.Mecsas
(2010).
The C-terminal tail of Yersinia pseudotuberculosis YopM is critical for interacting with RSK1 and for virulence.
|
| |
Infect Immun,
78,
2584-2598.
|
 |
|
|
|
|
 |
N.Dong,
L.Liu,
and
F.Shao
(2010).
A bacterial effector targets host DH-PH domain RhoGEFs and antagonizes macrophage phagocytosis.
|
| |
EMBO J,
29,
1363-1376.
|
 |
|
|
|
|
 |
S.W.Hicks,
and
J.E.Galán
(2010).
Hijacking the host ubiquitin pathway: structural strategies of bacterial E3 ubiquitin ligases.
|
| |
Curr Opin Microbiol,
13,
41-46.
|
 |
|
|
|
|
 |
T.Kubori,
N.Shinzawa,
H.Kanuka,
and
H.Nagai
(2010).
Legionella metaeffector exploits host proteasome to temporally regulate cognate effector.
|
| |
PLoS Pathog,
6,
e1001216.
|
 |
|
|
|
|
 |
C.M.Quezada,
S.W.Hicks,
J.E.Galán,
and
C.E.Stebbins
(2009).
A family of Salmonella virulence factors functions as a distinct class of autoregulated E3 ubiquitin ligases.
|
| |
Proc Natl Acad Sci U S A,
106,
4864-4869.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Bernal-Bayard,
and
F.Ramos-Morales
(2009).
Salmonella type III secretion effector SlrP is an E3 ubiquitin ligase for mammalian thioredoxin.
|
| |
J Biol Chem,
284,
27587-27595.
|
 |
|
|
|
|
 |
J.E.Galán
(2009).
Common themes in the design and function of bacterial effectors.
|
| |
Cell Host Microbe,
5,
571-579.
|
 |
|
|
|
|
 |
J.Song,
J.Wang,
A.A.Jozwiak,
W.Hu,
P.M.Swiderski,
and
Y.Chen
(2009).
Stability of thioester intermediates in ubiquitin-like modifications.
|
| |
Protein Sci,
18,
2492-2499.
|
 |
|
|
|
|
 |
T.Spallek,
S.Robatzek,
and
V.Göhre
(2009).
How microbes utilize host ubiquitination.
|
| |
Cell Microbiol,
11,
1425-1434.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |